PMC:3342329 / 9834-9977 JSONTXT

{"project":"test3","denotations":[{"id":"T5402","span":{"begin":8,"end":12},"obj":"Protein"},{"id":"T5394","span":{"begin":8,"end":12},"obj":"Protein"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"testone","denotations":[{"id":"T5389","span":{"begin":13,"end":23},"obj":"Gene_expression"},{"id":"T5382","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R3676","pred":"themeOf","subj":"T5382","obj":"T5389"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"BioNLP16_Messiy","denotations":[{"id":"T5830","span":{"begin":13,"end":23},"obj":"Gene_expression"},{"id":"T5823","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R4012","pred":"themeOf","subj":"T5823","obj":"T5830"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"BioNLP16_DUT","denotations":[{"id":"T5629","span":{"begin":13,"end":23},"obj":"Gene_expression"},{"id":"T5622","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R3836","pred":"themeOf","subj":"T5622","obj":"T5629"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"pmc-enju-pas","denotations":[{"id":"T5530","span":{"begin":130,"end":137},"obj":"NN"},{"id":"T5529","span":{"begin":126,"end":129},"obj":"NN"},{"id":"T5528","span":{"begin":122,"end":125},"obj":"DT"},{"id":"T5527","span":{"begin":120,"end":121},"obj":"-COMMA-"},{"id":"T5526","span":{"begin":112,"end":120},"obj":"NN"},{"id":"T5525","span":{"begin":109,"end":111},"obj":"IN"},{"id":"T5524","span":{"begin":103,"end":108},"obj":"NN"},{"id":"T5523","span":{"begin":100,"end":102},"obj":"IN"},{"id":"T5522","span":{"begin":87,"end":99},"obj":"NN"},{"id":"T5521","span":{"begin":83,"end":86},"obj":"DT"},{"id":"T5520","span":{"begin":78,"end":82},"obj":"IN"},{"id":"T5519","span":{"begin":70,"end":77},"obj":"VB"},{"id":"T5518","span":{"begin":66,"end":69},"obj":"VB"},{"id":"T5517","span":{"begin":55,"end":65},"obj":"NN"},{"id":"T5516","span":{"begin":49,"end":54},"obj":"NN"},{"id":"T5515","span":{"begin":45,"end":48},"obj":"DT"},{"id":"T5514","span":{"begin":37,"end":44},"obj":"IN"},{"id":"T5513","span":{"begin":28,"end":36},"obj":"VB"},{"id":"T5512","span":{"begin":25,"end":27},"obj":"TO"},{"id":"T5511","span":{"begin":13,"end":23},"obj":"NN"},{"id":"T5510","span":{"begin":8,"end":12},"obj":"NN"},{"id":"T5509","span":{"begin":5,"end":7},"obj":"IN"},{"id":"T5508","span":{"begin":1,"end":4},"obj":"CC"}],"relations":[{"id":"R3723","pred":"arg2Of","subj":"T5509","obj":"T5508"},{"id":"R3724","pred":"arg2Of","subj":"T5511","obj":"T5509"},{"id":"R3725","pred":"arg1Of","subj":"T5511","obj":"T5510"},{"id":"R3726","pred":"arg1Of","subj":"T5513","obj":"T5512"},{"id":"R3727","pred":"arg1Of","subj":"T5517","obj":"T5515"},{"id":"R3728","pred":"arg1Of","subj":"T5517","obj":"T5516"},{"id":"R3729","pred":"arg1Of","subj":"T5517","obj":"T5518"},{"id":"R3730","pred":"arg2Of","subj":"T5517","obj":"T5519"},{"id":"R3731","pred":"arg2Of","subj":"T5519","obj":"T5513"},{"id":"R3732","pred":"arg1Of","subj":"T5519","obj":"T5514"},{"id":"R3733","pred":"arg2Of","subj":"T5519","obj":"T5518"},{"id":"R3734","pred":"arg1Of","subj":"T5519","obj":"T5520"},{"id":"R3735","pred":"arg2Of","subj":"T5522","obj":"T5520"},{"id":"R3736","pred":"arg1Of","subj":"T5522","obj":"T5521"},{"id":"R3737","pred":"arg1Of","subj":"T5522","obj":"T5523"},{"id":"R3738","pred":"arg1Of","subj":"T5522","obj":"T5525"},{"id":"R3739","pred":"arg2Of","subj":"T5524","obj":"T5523"},{"id":"R3740","pred":"arg2Of","subj":"T5526","obj":"T5525"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"bionlp-st-ge-2016-test-proteins","denotations":[{"id":"T5444","span":{"begin":8,"end":12},"obj":"Protein"}],"namespaces":[{"prefix":"_base","uri":"http://bionlp.dbcls.jp/ontology/ge.owl#"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"bionlp-st-ge-2016-uniprot","denotations":[{"id":"T5794","span":{"begin":8,"end":12},"obj":"http://www.uniprot.org/uniprot/P51681"}],"namespaces":[{"prefix":"_base","uri":"http://www.uniprot.org/uniprot/"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"GO-MF","denotations":[{"id":"T5463","span":{"begin":130,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0005488"},{"id":"T5461","span":{"begin":126,"end":137},"obj":"http://purl.obolibrary.org/obo/GO_0003677"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"simple1","denotations":[{"id":"T5474","span":{"begin":8,"end":12},"obj":"Protein"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"DLUT931","denotations":[{"id":"T5808","span":{"begin":13,"end":23},"obj":"Gene_expression"},{"id":"T5801","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R4002","pred":"themeOf","subj":"T5801","obj":"T5808"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"bionlp-st-ge-2016-test-ihmc","denotations":[{"id":"T5903","span":{"begin":83,"end":120},"obj":"Negative_regulation"},{"id":"T5900","span":{"begin":8,"end":23},"obj":"Gene_expression"},{"id":"T5897","span":{"begin":100,"end":108},"obj":"Protein"},{"id":"T5887","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R4050","pred":"themeOf","subj":"T5887","obj":"T5900"},{"id":"R4053","pred":"themeOf","subj":"T5897","obj":"T5903"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"bionlp-st-ge-2016-spacy-parsed","denotations":[{"id":"T17919","span":{"begin":23,"end":24},"obj":"."},{"id":"T5689","span":{"begin":130,"end":137},"obj":"JJ"},{"id":"T5688","span":{"begin":126,"end":129},"obj":"NNP"},{"id":"T5687","span":{"begin":122,"end":125},"obj":"DT"},{"id":"T5686","span":{"begin":120,"end":121},"obj":","},{"id":"T5685","span":{"begin":112,"end":120},"obj":"NN"},{"id":"T5684","span":{"begin":109,"end":111},"obj":"IN"},{"id":"T5683","span":{"begin":103,"end":108},"obj":"NN"},{"id":"T5682","span":{"begin":100,"end":102},"obj":"IN"},{"id":"T5681","span":{"begin":87,"end":99},"obj":"NN"},{"id":"T5680","span":{"begin":83,"end":86},"obj":"DT"},{"id":"T5679","span":{"begin":78,"end":82},"obj":"IN"},{"id":"T5678","span":{"begin":70,"end":77},"obj":"VBN"},{"id":"T5677","span":{"begin":66,"end":69},"obj":"VBD"},{"id":"T5676","span":{"begin":55,"end":65},"obj":"NN"},{"id":"T5675","span":{"begin":49,"end":54},"obj":"NN"},{"id":"T5674","span":{"begin":45,"end":48},"obj":"DT"},{"id":"T5673","span":{"begin":37,"end":44},"obj":"IN"},{"id":"T5672","span":{"begin":28,"end":36},"obj":"VB"},{"id":"T5671","span":{"begin":25,"end":27},"obj":"TO"},{"id":"T5670","span":{"begin":23,"end":24},"obj":"."},{"id":"T5669","span":{"begin":13,"end":23},"obj":"NN"},{"id":"T5668","span":{"begin":8,"end":12},"obj":"CD"},{"id":"T5667","span":{"begin":5,"end":7},"obj":"IN"},{"id":"T5666","span":{"begin":1,"end":4},"obj":"CC"}],"relations":[{"id":"R3877","pred":"amod","subj":"T5668","obj":"T5669"},{"id":"R3878","pred":"pobj","subj":"T5669","obj":"T5667"},{"id":"R3880","pred":"aux","subj":"T5671","obj":"T5672"},{"id":"R3882","pred":"mark","subj":"T5673","obj":"T5678"},{"id":"R3883","pred":"det","subj":"T5674","obj":"T5676"},{"id":"R3884","pred":"compound","subj":"T5675","obj":"T5676"},{"id":"R3885","pred":"nsubjpass","subj":"T5676","obj":"T5678"},{"id":"R3886","pred":"auxpass","subj":"T5677","obj":"T5678"},{"id":"R3887","pred":"advcl","subj":"T5678","obj":"T5672"},{"id":"R3888","pred":"prep","subj":"T5679","obj":"T5678"},{"id":"R3889","pred":"det","subj":"T5680","obj":"T5681"},{"id":"R3890","pred":"pobj","subj":"T5681","obj":"T5679"},{"id":"R3891","pred":"prep","subj":"T5682","obj":"T5681"},{"id":"R3892","pred":"pobj","subj":"T5683","obj":"T5682"},{"id":"R3893","pred":"prep","subj":"T5684","obj":"T5681"},{"id":"R3894","pred":"pobj","subj":"T5685","obj":"T5684"},{"id":"R3895","pred":"punct","subj":"T5686","obj":"T5681"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}

{"project":"bionlp-st-ge-2016-test-tees","denotations":[{"id":"T5843","span":{"begin":130,"end":137},"obj":"Binding"},{"id":"T5842","span":{"begin":87,"end":99},"obj":"Negative_regulation"},{"id":"T5840","span":{"begin":103,"end":108},"obj":"Protein"},{"id":"T5839","span":{"begin":13,"end":23},"obj":"Gene_expression"},{"id":"T5837","span":{"begin":8,"end":12},"obj":"Protein"}],"relations":[{"id":"R4020","pred":"themeOf","subj":"T5837","obj":"T5839"},{"id":"R4021","pred":"themeOf","subj":"T5840","obj":"T5842"}],"text":" and in CCR5 expression. To evaluate whether the tumor inhibition was related with the inactivation of NF-κB in melanoma, the DNA binding activ"}